II.·iv. Anti-inflammatories · 3 of 7

Berberine the natural AMPK metformin

Isoquinoline alkaloid from Berberis aristata · potent AMPK activator comparable to metformin (Yin 2008+2024). Lan 2024 meta-analysis: HbA1c −0.7%, LDL −20%, weight −2 kg, SBP −7 mmHg. DHB (dihydroberberine) +5x bioavailability.

Robust T2D + lipid evidence1,000–1,500 mgberberine/dayDHB +5xbioavailability~25 €/monthstandard
7Berberine appears in 7 protocols personalizable
Optimal dose
500 mg × 3
split with meals
Best form
Dihydroberberine (DHB)
+5x bioavailability
Hallmarks
AMPK · Glucose · Microbiota
metformin-like pathway
Top synergy
+ Cr + Inositol
canon T2D + PCOS stack
i.

What is berberine

Yellow isoquinoline alkaloid · present in Berberis aristata (barberry), Coptis chinensis · used millennia in Chinese medicine. Potent AMPK activator · metformin-like action.

Berberine is a bright yellow isoquinoline alkaloid extracted from roots of plants Berberis aristata (barberry), Coptis chinensis (Chinese goldenseal), Hydrastis canadensis and Phellodendron. Used for millennia in Traditional Chinese Medicine (Huang Lian) and India (Daru Haridra). Its great modern discovery: potent activation of AMPK (AMP-activated protein kinase), the cellular energy master switch, via identical pathway to metformin (Yin 2008+2024).

Expanded mechanism: AMPK activation → muscle glucose uptake GLUT4 + hepatic gluconeogenesis inhibition · intestinal microbiota modulation (increases Akkermansia muciniphila, reduces Firmicutes/Bacteroidetes ratio) · PCSK9 inhibition (similar mechanism to statins for LDL) · senescence + autophagy. Lan 2024 meta-analysis 50 RCTs n=4,480: HbA1c −0.7%, LDL −20%, TG −18%, weight −2 kg, SBP −7 mmHg. Comparable to metformin 1,500 mg/day without lactoacidosis. Limitation: berberine HCl oral bioavailability ~5% · dihydroberberine (DHB) form multiplies absorption ~5x.

«Berberine activates AMPK with potency comparable to metformin and modulates gut microbiota in ways that compound its metabolic benefits · the combination of glucose, lipid, and weight effects from a natural compound is unmatched in nutraceuticals · DHB form addresses the bioavailability problem.» Jianping Ye · Pennington Biomedical · J Diabetes 2024 update
−0.7%
HbA1c with berberine 1,500 mg/d × 12-24 weeks (comparable to metformin without lactoacidosis · meta 50 RCTs n=4,480).
Source · Lan · J Ethnopharmacol 2024 update
ii.

Clinical evidence of berberine in humans

5 pivotal studies · coverage of T2D Lan meta, PCOS fertility, NAFLD, dyslipidemia, microbiota.

StudyFindingHallmarks
Berberine meta-analysis T2D + lipids
Lan et al · J Ethnopharmacol 2024 update
Meta-analysis 50 RCTs n=4,480 · 500-1,500 mg berberine/d × 8-24 weeks · HbA1c −0.7%, basal glucose −1.2 mmol/L, LDL −20%, TG −18%, SBP −7 mmHg, weight −2 kg.T2DLipids
Berberine PCOS fertility vs metformin
An et al · Reprod Biol Endocrinol 2024
RCT n=120 PCOS · 500 mg berberine × 3/day vs metformin 500 mg × 3 × 12 weeks · equivalent HOMA-IR, ovulation 39% vs 25% metformin, pregnancy +18%.PCOSFertility
Berberine NAFLD biopsy
Yan et al · Hepatology Communications 2024
RCT n=184 biopsy NAFLD · 500 mg × 3/d × 24 weeks · hepatic steatosis −51% (MR-MRS), ALT −34%, weight −2.8 kg vs placebo.NAFLDLiver
DHB bioavailability vs berberine HCl
Bao et al · J Med Food 2024
Crossover n=24 · 100 mg DHB vs 100 mg berberine HCl · DHB plasma peak +5.2x, AUC +480%, t1/2 7.2h vs 2.4h. Digestive tolerance +50% better.PKBioAv.
My Protocol · free

Is Berberine right for your case? It cross-references your age, biomarkers and medication.

My Protocol generates 3 personalized plans with exact form, dose and combos based on your profile. No commitment.

Generate free →
iii.

Hallmarks of Aging targeted

López-Otín 2023 maps 12 aging hallmarks · direct impact (gold-deep) and indirect (sage).

GenomicinstabilityDNArepairTelomereattritionEpigen.alteredProteo.lossNutrientsensingMito.functionCellularsenescenceStem cellexhaust.Alteredcomm.Chronicinflamm.DysbiosisDisabledautophagy
Direct impact (2)Indirect impact (4)Not impacted (6)
Dose-response · human evidence
HbA1c reduction based on berberine dose
0−0.3−0.5−0.7−1.03005001,0001,5002,0003,000 mg/dayPlateau ≈ 1,500-2,000 mg/d
Reading · Curve derived from Lan 2024. Significant HbA1c reduction from 500 mg · plateau 1,500-2,000 mg. Chronic doses >2,500 mg without extra benefit · GI adverse increase (diarrhea, cramps). (View analysis →)
iv.

Berberine dose · how much, when and how

4-phase protocol · DHB for tolerance and bioavailability · mandatory split with meals (short half-life + GI).

Phase 1Soft start

Tolerance test

500 mg berberine × 1/day with meal

Start low · evaluate GI tolerance (diarrhea, cramps frequent with sulfate/HCl). Mandatory take with food. Maintain 1-2 weeks before increasing.

Phase 2Metabolic maintenance

Canon Lan dose

500 mg × 3/day (1,500 mg total) split

T2D, prediabetes, PCOS, dyslipidemia. Split pre-meals morning + lunch + dinner. Lan 2024 HbA1c −0.7%. Re-measure HbA1c + lipids + ALT at 12 weeks.

Phase 3NAFLD/MASH

Canon Yan dose

500 mg × 3/d × 24 weeks

Biopsy-confirmed NAFLD · under hepatology. Yan 2024 steatosis −51%, ALT −34%. Combine with vit E mix + TMG if budget. Re-FibroScan/MRS at 24 weeks.

Phase 4DHB pro form

Canon Dihydroberberine

100-200 mg DHB × 2/day (equivalent 500-1,000 mg berberine HCl)

Subjects intolerant of berberine HCl GI or wanting superior PK. Bao 2024 +5x bioavailability · tolerance +50% better. Higher cost but lower dose.

v.

Berberine HCl vs DHB vs Berberine phytosome · which to choose

3 distinct forms · HCl classic RCTs · DHB superior PK · phytosome intermediate.

Berberine HClBerberis aristata extract hydrochloride
ProsForm used in 90% canon RCTs (Lan, Yan, An). Economical (~15-25 €/month). Standardized typical 97% purity.
ConsOral bioavailability ~5% · GI adverse 20-30% subjects (diarrhea, cramps, paradoxical constipation). Short half-life 2-4h · mandatory splitting.
Ideal use: replicate canon RCTs · normal digestive tolerance · medium budget.
Dihydroberberine (DHB)Pre-metabolized reduced form
ProsOral bioavailability +5x HCl (Bao 2024). GI tolerance +50% better. Half-life 7.2h vs 2.4h. Lower dose required.
ConsExpensive (~35-50 €/month). Limited availability · only premium brands. Limited head-to-head RCTs.
Ideal use: HCl GI intolerant · want superior PK · pro budget.
Berberine phytosome (lipid carrier)Phospholipidic Quercefit-type · Indena
ProsBioavailability ~3x HCl. Better GI tolerance vs HCl. Intermediate form.
ConsExpensive · limited availability in Spain. Limited specific RCTs.
Ideal use: intermediate HCl-DHB alternative · if DHB unavailable.
vi.

Best Berberine brands · Spain 2026

3 tiers · HCl Thorne/NOW canon RCTs · DHB GlucoVantage premium · verifiable HPLC COA.

Premium

GlucoVantage DHB (Dihydroberberine) 100 mg

42 € · 60 capsules (2 months at 1 cap × 2/day)

Dose: 100 mg DHB/capsule

Form: Pre-metabolized dihydroberberine · NNB Nutrition patented

Cert.: USA GMP · cGMP · third-party tested · public COA

Fillers: HPMC capsule + microcrystalline cellulose. Zero.

NNB Nutrition ESaffComing sooniHerbaffComing soon
Medio

Thorne Berberine 500 mg

26 € · 60 capsules (1 month at 1,500 mg/d)

Dose: 500 mg berberine HCl/capsule (3 caps = 1,500 mg/d)

Form: Berberine HCl 97% purity standardized

Cert.: USA GMP · cGMP · NSF · third-party tested

Fillers: HPMC capsule + microcrystalline cellulose. No stearate.

Thorne SpainaffComing sooniHerbaffComing soon
Económica

Now Foods Berberine Glucose Support 500 mg

18 € · 90 capsules (1 month at 1,500 mg/d)

Dose: 500 mg berberine HCl + 10 mg MCT/capsule

Form: Berberine HCl + MCT (improves absorption)

Cert.: USA GMP · Informed Sport · USP

Fillers: Cellulose, magnesium stearate (common, OK).

iHerbaffComing soonAmazon SpainaffComing soon
My Protocol · free

Not sure which brand to choose for your case?

My Protocol recommends form + brand + exact dose based on your age, budget and biomarkers. No commitment · 3 minutes.

Recommend brand →
vii.

Markers · HbA1c + lipids + ALT + microbiota

4 biomarkers · pre/post 12 weeks to verify metabolic + hepatic + lipid response.

HbA1c + HOMA-IR. Optimal range HbA1c <5.6% · HOMA-IR <1.5. Falls with berberine 1.5 g × 12-24 weeks (Lan 2024 HbA1c −0.7%). Cost ~40-60 € panel.

Complete lipids (LDL + ApoB + lp(a) + TG). Lan 2024: LDL −20%, TG −18%, ApoB −15%. Cost ~25-40 € cardiometabolic panel.

ALT + AST (liver). Falls with berberine NAFLD (Yan 2024 ALT −34%). Cost ~10-15 € liver panel.

Microbiota (Akkermansia + Firmicutes/Bacteroidetes). Berberine increases Akkermansia muciniphila · useful pre/post if budget. 16S rRNA Sequencing test available Microba/Tecsalud (~250-450 €).

Related analysis · verified clinics

Cardiometabolic + liver panel in 14 clinics Spain · from 80 €

HbA1c + HOMA-IR + ApoB lipids + ALT/AST + insulin. Complete cardiometabolic + hepatic panel · useful pre/post 12 weeks berberine ± Cr + inositol. We verify clinics in-situ.

14Verified clinics
80–180 €Panel price range
48-72hResults
4.7/5Average score
View 14 clinics →
viii.

Berberine interactions · precaution contexts

Particular attention: hypoglycemics, potent CYP3A4 inhibition, pregnancy CONTRAINDICATED.

Consult healthcare professional if
  • Hypoglycemics (insulin, sulfonylureas): berberine potentiates glycemic response · paradoxical hypoglycemia risk with poorly adjusted doses. Monitor glucose + adjust insulin with endocrinologist. Functional endocrinology →
  • CYP3A4 substrates (cyclosporine, statins, anticoagulants): berberine potent CYP3A4 inhibitor (similar to grapefruit juice). Elevates plasma levels · adjust dose under doctor. Special care with cyclosporine + tacrolimus.
  • PREGNANCY CONTRAINDICATED: berberine crosses placenta · documented neonatal kernicterus in newborns exposed in late gestation. NEVER supplement during pregnancy.
  • Lactation: berberine present in breast milk · may cause neonatal hyperbilirubinemia. Pause during lactation.
  • Neonates / children &lt;3 years: immature bilirubin metabolism · contraindicated. NEVER give pediatric berberine.
+5x
oral bioavailability DHB (dihydroberberine) vs berberine HCl · 7.2h half-life vs 2.4h.
Source · Bao · J Med Food 2024
x.

Berberine frequently asked questions

8 real questions · answers based on Lan + Yan + An + Bao + Ye literature.

Does it replace metformin?
Comparable to metformin 1,500 mg/d in HbA1c reduction (An 2024 PCOS equivalents). BUT metformin has 60 years evidence + official T2D indication. Berberine can be adjuvant or alternative in pre-diabetes/PCOS under functional doctor. NEVER replace metformin without endocrinology.
Berberine HCl or DHB?
HCl if medium budget + normal GI tolerance · canon RCT form. DHB if HCl intolerant (GI adverse) or want superior PK (+5x bioavailability · Bao 2024). DHB expensive 35-50 €/month vs HCl 15-25 €/month.
Does it cause diarrhea?
Yes · GI adverse 20-30% subjects berberine HCl (diarrhea, cramps, paradoxical constipation). Start 500 mg/d with mandatory food · ramp up gradual. DHB better tolerated 50% fewer adverse (Bao).
With or without food?
ALWAYS with food. Reduces GI adverse + synergy insulin response to carbohydrate. Split pre-meals morning + lunch + dinner. Without food: high probability cramps + diarrhea.
How long until I notice effects?
HbA1c: 12-24 weeks (Lan). LDL: 8-12 weeks. NAFLD ALT: 24 weeks (Yan). PCOS HOMA-IR: 12 weeks (An). Subjective: post-meal glucose stabilizes 1-2 weeks.
Pregnancy and lactation?
CONTRAINDICATED pregnancy and lactation. Berberine crosses placenta + breast milk · documented neonatal kernicterus. NEVER supplement gestation. Pause 3 months before seeking pregnancy.
What about microbiota?
Berberine selective antibacterial (not broad spectrum like antibiotic). Increases Akkermansia muciniphila · reduces Firmicutes/Bacteroidetes ratio. Useful metabolic dysbiosis. Some subjects feel initial 2-4 week digestive change.
Is it safe long-term?
Yes at doses 1-1.5 g/d ≤24 months documented. CYP3A4 inhibition is the principal consideration · careful combos. >2 year cohorts limited · respect standard doses.
xii.

Related

Supplements · treatments · biomarkers for your complete protocol.

My Protocol

Not sure where to start?

My Protocol cross-references +500 clinical parameters and generates 3 personalized plans with supplements, treatments and biomarkers adapted to your case.

Generate My Protocol free →